Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 3,365 | 2,461 | 2,240 | 11,886 | 1,836 |
| Operating Income | -3,365 | -2,461 | -2,240 | -11,886 | -1,836 |
| Other Income | -3 | -36 | 12 | -7 | 10 |
| Pre-tax Income | -3,368 | -2,497 | -2,228 | -11,893 | -1,826 |
| Net Income Continuous | -3,368 | -2,497 | -2,228 | -11,893 | -1,826 |
| Net Income Discontinuous | N/A | N/A | N/A | -173 | -104 |
| Net Income | $-3,368 | $-2,497 | $-2,228 | $-12,066 | $-1,930 |
| EPS Basic Total Ops | -699.30 | -524.48 | -437.06 | -3,059.44 | -437.06 |
| EPS Basic Continuous Ops | -659.30 | -488.80 | -436.66 | -2,913.63 | -478.13 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -18.87 | -27.23 |
| EPS Diluted Total Ops | -699.30 | -524.48 | -437.06 | -3,059.44 | -437.06 |
| EPS Diluted Continuous Ops | -659.30 | -488.80 | -436.66 | -2,913.63 | -478.13 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -18.87 | -27.23 |
| EBITDA(a) | $-3,355 | $-2,449 | $-2,229 | $-11,874 | $-1,824 |